{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:19:36Z","timestamp":1768407576022,"version":"3.49.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["111-2320-B-038-058-MY2"],"award-info":[{"award-number":["111-2320-B-038-058-MY2"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.lfs.2023.122327","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T02:59:17Z","timestamp":1701831557000},"page":"122327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Treatment with a new barbituric acid derivative suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice"],"prefix":"10.1016","volume":"336","author":[{"given":"Fat-Moon","family":"Suk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Yu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Hua","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Chun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Chieh","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Lang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Jen","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2023.122327_bb0005","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lfs.2023.122327_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.lfs.2023.122327_bb0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.lfs.2023.122327_bb0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122327_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.lfs.2023.122327_bb0030","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122327_bb0035","first-page":"76","article-title":"Non-alcoholic fatty liver disease: growing burden, adverse outcomes and associations","volume":"8","author":"Kumar","year":"2020","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122327_bb0040","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2023.122327_bb0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jlac.18641300202","article-title":"Untersuchungen \u00fcber die Harnsauregruppe","volume":"130","author":"Baeyer","year":"1864","journal-title":"Ann. der Chem."},{"issue":"4","key":"10.1016\/j.lfs.2023.122327_bb0050","first-page":"329","article-title":"The history of barbiturates a century after their clinical introduction","volume":"1","author":"Lopez-Munoz","year":"2005","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.lfs.2023.122327_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.msec.2016.04.056","article-title":"A new synthetic methodology for the preparation of biocompatible and organo-soluble barbituric- and thiobarbituric acid based chitosan derivatives for biomedical applications","volume":"66","author":"Shahzad","year":"2016","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.lfs.2023.122327_bb0060","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1007\/s00044-014-0973-5","article-title":"Hybrid probes of aromatic amine and barbituric acid: highly promising leads for anti-bacterial, anti-fungal and anti-cancer activities","volume":"23","author":"Dhorajiya","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.lfs.2023.122327_bb0065","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jfluchem.2012.06.032","article-title":"Synthesis and biological evaluation of new barbituric and thiobarbituric acid fluoro analogs of benzenesulfonamides as antidiabetic and antibacterial agents","volume":"142","author":"HMFaKA","year":"2012","journal-title":"J. Fluor. Chem."},{"issue":"7","key":"10.1016\/j.lfs.2023.122327_bb0070","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0006-2952(93)90477-E","article-title":"5-Benzylbarbituric acid derivatives, potent and specific inhibitors of uridine phosphorylase","volume":"46","author":"Naguib","year":"1993","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.lfs.2023.122327_bb0075","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1007\/s12010-013-0486-6","article-title":"Antibacterial, antiurease, and antioxidant activities of some arylidene barbiturates","volume":"171","author":"Sokmen","year":"2013","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122327_bb0080","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.bmc.2014.12.037","article-title":"Design and synthesis of new bioisosteres of spirooxindoles (MI-63\/219) as anti-breast cancer agents","volume":"23","author":"Kumar","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.lfs.2023.122327_bb0085","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.ejmech.2017.11.006","article-title":"Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells","volume":"143","author":"Ramisetti","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.lfs.2023.122327_bb0090","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.intimp.2016.06.004","article-title":"Anti-inflammatory effects of novel barbituric acid derivatives in T lymphocytes","volume":"38","author":"Xu","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"11","key":"10.1016\/j.lfs.2023.122327_bb0095","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.bmcl.2009.04.014","article-title":"Design, synthesis and anticancer activities of hybrids of indole and barbituric acids--identification of highly promising leads","volume":"19","author":"Singh","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.lfs.2023.122327_bb0100","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12154-015-0148-y","article-title":"Photochemical synthesis and anticancer activity of barbituric acid, thiobarbituric acid, thiosemicarbazide, and isoniazid linked to 2-phenyl indole derivatives","volume":"9","author":"Laxmi","year":"2016","journal-title":"J. Chem. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122327_bb0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bmcl.2018.12.026","article-title":"N-Naphthoyl-substituted indole thio-barbituric acid analogs inhibit the helicase activity of the hepatitis C virus NS3","volume":"29","author":"Marecki","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.lfs.2023.122327_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fphar.2020.00388","article-title":"Antifibrotic effects of a barbituric acid derivative on liver fibrosis by blocking the NF-kappaB signaling pathway in hepatic stellate cells","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.lfs.2023.122327_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25122856","article-title":"Treatment with a new barbituric acid derivative exerts antiproliferative and antimigratory effects against sorafenib resistance in hepatocellular carcinoma","volume":"25","author":"Liao","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.lfs.2023.122327_bb0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.31887\/DCNS.2017.19.2\/wcarlezon","article-title":"Behavioral methods to study anxiety in rodents","volume":"19","author":"Lezak","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"issue":"17","key":"10.1016\/j.lfs.2023.122327_bb0125","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.lfs.2023.122327_bb0130","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","article-title":"Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance","volume":"51","author":"Schwenzer","year":"2009","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122327_bb0135","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/brv.12178","article-title":"De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose","volume":"91","author":"Sanders","year":"2016","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"issue":"18","key":"10.1016\/j.lfs.2023.122327_bb0140","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.lfs.2023.122327_bb0145","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122327_bb0150","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cmet.2006.08.005","article-title":"Lipin 1 is an inducible amplifier of the hepatic PGC-1 alpha\/PPAR alpha regulatory pathway","volume":"4","author":"Finck","year":"2006","journal-title":"Cell Metab."},{"issue":"41","key":"10.1016\/j.lfs.2023.122327_bb0155","doi-asserted-by":"crossref","first-page":"27816","DOI":"10.1074\/jbc.M109.022467","article-title":"Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.lfs.2023.122327_bb0160","article-title":"The overlooked transformation mechanisms of VLCFAs: peroxisomal beta-oxidation","volume":"12","author":"Lu","year":"2022","journal-title":"Agriculture-Basel"},{"key":"10.1016\/j.lfs.2023.122327_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.lfs.2023.122327_bb0170","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.lfs.2023.122327_bb0175","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrendo.2011.72","article-title":"Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment","volume":"7","author":"Smith","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122327_bb0180","doi-asserted-by":"crossref","first-page":"G13","DOI":"10.1530\/JOE-14-0182","article-title":"Metabolic phenotyping guidelines: assessing glucose homeostasis in rodent models","volume":"222","author":"Bowe","year":"2014","journal-title":"J. Endocrinol."},{"issue":"9","key":"10.1016\/j.lfs.2023.122327_bb0185","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep4.1541","article-title":"Nonalcoholic fatty liver disease increases the risk of anxiety and depression","volume":"4","author":"Labenz","year":"2020","journal-title":"Hepatol. Commun."},{"issue":"6","key":"10.1016\/j.lfs.2023.122327_bb0190","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","article-title":"Pathophysiology of obesity and its associated diseases","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.lfs.2023.122327_bb0195","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2741\/4892","article-title":"Current treatment paradigms and emerging therapies for NAFLD\/NASH","volume":"26","author":"Raza","year":"2021","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"8","key":"10.1016\/j.lfs.2023.122327_bb0200","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.7150\/ijbs.33837","article-title":"Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer","volume":"15","author":"Cheng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.lfs.2023.122327_bb0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuroscience.2020.04.034","article-title":"Recent updates on obesity treatments: available drugs and future directions","volume":"437","author":"Dragano","year":"2020","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.lfs.2023.122327_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.lfs.2023.122327_bb0215","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jhep.2020.04.025","article-title":"Differential effects of selective- and pan-PPAR agonists on experimental steatohepatitis and hepatic macrophages(\u2606)","volume":"73","author":"Lefere","year":"2020","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122327_bb0220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2010","journal-title":"QJM Int. J. Med."},{"issue":"1","key":"10.1016\/j.lfs.2023.122327_bb0225","doi-asserted-by":"crossref","first-page":"78","DOI":"10.14218\/JCTH.2014.00037","article-title":"Nonalcoholic fatty liver disease: dyslipidemia, risk for cardiovascular complications, and treatment strategy","volume":"3","author":"Zhang","year":"2015","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122327_bb0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin. Liver Dis."},{"issue":"9","key":"10.1016\/j.lfs.2023.122327_bb0235","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122327_bb0240","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"22","author":"Dharmalingam","year":"2018","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.lfs.2023.122327_bb0245","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.lfs.2023.122327_bb0250","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3350\/cmh.2020.0137","article-title":"Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease","volume":"26","author":"Kim","year":"2020","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.lfs.2023.122327_bb0255","doi-asserted-by":"crossref","first-page":"16065","DOI":"10.1038\/nrdp.2016.65","article-title":"Major depressive disorder","volume":"2","author":"Otte","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.lfs.2023.122327_bb0260","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1037\/rev0000157","article-title":"Life stress and major depression: the mysteries of recurrences","volume":"126","author":"Monroe","year":"2019","journal-title":"Psychol. Rev."},{"issue":"10053","key":"10.1016\/j.lfs.2023.122327_bb0265","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Disease","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2023.122327_bb0270","doi-asserted-by":"crossref","DOI":"10.1017\/S204579602000116X","article-title":"Depression and increased risk of non-alcoholic fatty liver disease in individuals with obesity","volume":"30","author":"Cho","year":"2021","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.lfs.2023.122327_bb0275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jad.2021.12.128","article-title":"Association between nonalcoholic fatty liver disease and depression: a systematic review and meta-analysis of observational studies","volume":"301","author":"Gu","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.lfs.2023.122327_bb0280","first-page":"12","article-title":"Interaction mechanisms between major depressive disorder and non-alcoholic fatty liver disease","author":"Shao","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.lfs.2023.122327_bb0285","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2020.09.073","article-title":"Association between depression and nonalcoholic fatty liver disease: Contributions of insulin resistance and inflammation","volume":"278","author":"Lee","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.lfs.2023.122327_bb0290","first-page":"8","article-title":"Is fatty liver associated with depression? A meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease","author":"Xiao","year":"2021","journal-title":"Front. Med. Lausanne"},{"key":"10.1016\/j.lfs.2023.122327_bb0295","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jad.2023.07.005","article-title":"A unique inflammation-related mechanism by which high-fat diets induce depression-like behaviors in mice","volume":"339","author":"Yu","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.lfs.2023.122327_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113949","article-title":"High fat diet-induced obesity leads to depressive and anxiety-like behaviors in mice via AMPK\/mTOR-mediated autophagy","volume":"348","author":"Li","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.lfs.2023.122327_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1068164","article-title":"Inflammation-activated C\/EBP\u03b2 mediates high-fat diet-induced depression-like behaviors in mice","volume":"15","author":"Li","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.lfs.2023.122327_bb0310","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1176\/appi.ajp.161.11.1957","article-title":"Hippocampal volume and depression: a meta-analysis of MRI studies","volume":"161","author":"Videbech","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.lfs.2023.122327_bb0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1176\/ajp.157.1.115","article-title":"Hippocampal volume reduction in major depression","volume":"157","author":"Bremner","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.lfs.2023.122327_bb0320","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1210\/clinem\/dgad352","article-title":"The presence and severity of NAFLD are associated with cognitive impairment and hippocampal damage","volume":"108","author":"Miao","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15","key":"10.1016\/j.lfs.2023.122327_bb0325","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-5168","article-title":"Effect of combined chronic predictable and unpredictable stress on depression-like symptoms in mice","volume":"8","author":"Qiao","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.lfs.2023.122327_bb0330","first-page":"9","article-title":"Dusp8 affects hippocampal size and behavior in mice and humans","author":"Baumann","year":"2019","journal-title":"Sci. Rep. UK"},{"issue":"3","key":"10.1016\/j.lfs.2023.122327_bb0335","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies","volume":"67","author":"Luppino","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.lfs.2023.122327_bb0340","first-page":"5917","article-title":"Shared biological mechanisms of depression and obesity: focus on adipokines and lipokines","volume":"15","author":"Fu","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.lfs.2023.122327_bb0345","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.psychres.2017.01.012","article-title":"Physical exercise ameliorates mood disorder-like behavior on high fat diet-induced obesity in mice","volume":"250","author":"Park","year":"2017","journal-title":"Psychiatry Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:20:35Z","timestamp":1758403235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523009621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":69,"alternative-id":["S0024320523009621"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122327","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with a new barbituric acid derivative suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122327"}}